Skip to content

Circles

T

Turn Therapeutics Inc.

TTRX· Nasdaq

T

TTRXTurn Therapeutics Inc.

TTRXTurn Therapeutics Inc.·Earnings record

Q4 2024

Source filing unavailable

Previous · Q3 2024 Next · Q1 2025

Q4 2024 · —

derived · Computed from the longer spans the company filed.

Revenue—

Net income—

EPS, diluted—Not derived. Share counts vary by quarter.

Operating Cash Flowderived-$430,545—

Same quarter

no prior Q4 2023 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Filing lag

Quarterly history

Q3 ’24Q4 ’24^dQ1 ’25 Q2 ’25 Q3 ’25 Q4 ’25^d Q1 ’26 Q2 ’26

Turn Therapeutics Inc. · CIK 2023016 · Engraved from SEC EDGAR

Thaler ResearchEngraved from SEC EDGAR© 2026 Thaler. All rights reserved.Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Platform

Using AI API SDKs CLI

Research

News Listen Earnings Insiders Holders Compare Metrics

Screener Watchlists Pies Notes Your companies

Learn

Thaler

Thaler Agent Promise Provenance Circles Account Terms Privacy